NASDAQ : INMB

INmune Bio, Inc. — Earnings Estimates

$1.75 USD

-$0.02 (-1.13%)

Volume
225.33K
Average Volume
781.08K
Market Capitalization
$46.52M
P/E Ratio
-1.04
Dividend Yield
0.00%
Price Target
$22.00
Year High
$2.96
Year Low
$1.09
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.24

Annual earnings financials

INMB financial data with annual/quarterly toggle

INMB GAAP EPS - Annual & Quarterly

INMB Sales Revenue - Annual & Quarterly

INMB Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

INMB Estimated and Actual Revenue by Quarter
INMB Estimated and Actual EPS by Quarter
INMB Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 3 -15.18M -15.18M -15.18M -15.18M -15.18M -15.18M
2027-09-30 0 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 0 - - - - - -
2026-12-31 5 -1.95M -1.95M -1.95M -1.95M -1.95M -1.95M
2026-09-30 4 -1.88M -1.88M -1.88M -1.88M -1.88M -1.88M
INMB Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 3 -3.46M -3.46M -3.46M 3.09B 3.09B 3.09B
2027-09-30 0 -3.46M -3.46M -3.46M - - -
2027-06-30 0 -3.46M -3.46M -3.46M - - -
2027-03-31 0 -6.51M -6.51M -6.51M - - -
2026-12-31 5 -5.32M -5.32M -5.32M 396.8M 396.8M 396.8M
2026-09-30 4 -6.33M -4.66M -5.49M 382.14M 382.14M 382.14M
INMB Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 3 15.18M 15.18M 15.18M 1 -0.13 -0.13 -0.13
2027-09-30 0 - - - 1 -0.13 -0.13 -0.13
2027-06-30 0 - - - 1 -0.13 -0.13 -0.13
2027-03-31 0 - - - 1 -0.245 -0.245 -0.245
2026-12-31 5 1.95M 1.95M 1.95M 1 -0.2 -0.2 -0.2
2026-09-30 4 1.88M 1.88M 1.88M 2 -0.23798 -0.17536 -0.20667